Avastin Secures Japanese Approval For Colorectal Cancer
This article was originally published in PharmAsia News
Executive Summary
Roche/Genentech's Avastin (bevacizumab) has become the first biologic approved to treat colorectal cancer in Japan; Roche's Japanese partner Chugai announced the approval April 18